346 related articles for article (PubMed ID: 16441638)
41. Fluoroquinolones, gonorrhea, and the CDC STD treatment guidelines.
Berman SM; Moran JS; Wang SA; Workowski KA
Sex Transm Dis; 2003 Jun; 30(6):528-9; author reply 530. PubMed ID: 12782957
[No Abstract] [Full Text] [Related]
42. Correlates of gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997.
Klausner JD; Aplasca MR; Mesola VP; Bolan G; Whittington WL; Holmes KK
J Infect Dis; 1999 Mar; 179(3):729-33. PubMed ID: 9952388
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
Chan DJ; Tapsall J
Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
[TBL] [Abstract][Full Text] [Related]
44. Non-penicillinase producing Neisseria gonnorhoeae: are they still in existence in Ibadan, Nigeria?
Bakare RA; Oni AA; Umar US; Kehinde AO; Fayemiwo SA; Alli OO
Afr J Med Med Sci; 2001 Dec; 30(4):281-3. PubMed ID: 14510104
[TBL] [Abstract][Full Text] [Related]
45. Ciprofloxacin resistance in gonococci.
Ison C; Martin I; Ivens D; Philip S; Greene L
Lancet; 2001 Mar; 357(9258):803. PubMed ID: 11253997
[No Abstract] [Full Text] [Related]
46. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam.
Cao V; Ratsima E; Van Tri D; Bercion R; Fonkoua MC; Richard V; Talarmin A
Sex Transm Dis; 2008 Nov; 35(11):941-5. PubMed ID: 18724270
[TBL] [Abstract][Full Text] [Related]
47. [Increased Neisseria gonorrhoeae quinolone resistance in Amsterdam].
Peerbooms PG; Spaargaren J; Fennema JS; Cairo I; Coutinho RA
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1899-900. PubMed ID: 11605315
[TBL] [Abstract][Full Text] [Related]
48. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1041-4. PubMed ID: 12487525
[TBL] [Abstract][Full Text] [Related]
49. Increased ciprofloxacin resistance in gonococci isolated in Scotland.
Forsyth A; Moyes A; Young H
Lancet; 2000 Dec; 356(9246):1984-5. PubMed ID: 11130531
[TBL] [Abstract][Full Text] [Related]
50. Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.
Sarwal S; Wong T; Sevigny C; Ng LK
CMAJ; 2003 Apr; 168(7):872-3. PubMed ID: 12668548
[No Abstract] [Full Text] [Related]
51. High-level ciprofloxacin-resistant Neisseria gonorrhoeae and heterosexually acquired infections in Victoria.
Griffith JM; Barclay LM; de Petra V; Forsyth JR; Hogg GG
Med J Aust; 1996 Jan; 164(2):125. PubMed ID: 8569567
[No Abstract] [Full Text] [Related]
52. Australian gonococcal surveillance programme, 1 April to 30 June 2014.
Lahra MM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E390-2. PubMed ID: 25631604
[No Abstract] [Full Text] [Related]
53. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
54. Nalidixic acid-susceptible, ciprofloxacin-resistant Neisseria gonorrhoeae strain in the UK.
Ragunathan PL; Ison C; Livermore DM
J Antimicrob Chemother; 2005 Aug; 56(2):437. PubMed ID: 15967768
[No Abstract] [Full Text] [Related]
55. [E-test quantitative determination for evaluating Neisseria gonorrhoeae resistance].
Filipiuc S; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1169-74. PubMed ID: 21500474
[TBL] [Abstract][Full Text] [Related]
56. A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.
Aplasca De Los Reyes MR; Pato-Mesola V; Klausner JD; Manalastas R; Wi T; Tuazon CU; Dallabetta G; Whittington WL; Holmes KK
Clin Infect Dis; 2001 May; 32(9):1313-8. PubMed ID: 11303266
[TBL] [Abstract][Full Text] [Related]
57. Ciprofloxacin resistance in Neisseria gonorrhoeae isolated in Mumbai (formerly Bombay), India.
Divekar A; Gogate A
Sex Transm Infect; 1999 Apr; 75(2):122. PubMed ID: 10448368
[No Abstract] [Full Text] [Related]
58. Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy?
Ivens D; Martin I; Ison C
Int J STD AIDS; 2000 Dec; 11(12):774-6. PubMed ID: 11138910
[TBL] [Abstract][Full Text] [Related]
59. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.
Vázquez JA; Martín E; Galarza P; Giménez MJ; Aguilar L; Coronel P
Int J Antimicrob Agents; 2007 Apr; 29(4):473-4. PubMed ID: 17276040
[No Abstract] [Full Text] [Related]
60. Ciprofloxacin resistance in Neisseria gonorrhoeae.
Moodley P; Sturm AW
Lancet; 2001 Apr; 357(9264):1295-6. PubMed ID: 11421219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
